Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Stephen J. Farr"'
Publikováno v:
Journal of Opioid Management. 11:405-415
Objectives: To assess the single-dose and steady-state pharmacokinetics of a single-entity hydrocodone extended-release (ER) formulation in patients enrolled in two separate phase 2 clinical studies . Setting: Both studies were multicenter clinical s
Publikováno v:
Clinical Pharmacokinetics. 52:907-917
Hydrocodone is a semi-synthetic narcotic analgesic and antitussive. Although hydrocodone products have been on the market for over 50 years, relatively little is known about its pharmacokinetics. Additionally, there are no published reports of popula
Autor:
Jan Lewis Brandes, Stephen J. Farr, Anthony W. Fox, Sheena K. Aurora, John F. Rothrock, Roger Cady, Judith A. Myers
Publikováno v:
Current Medical Research and Opinion. 27:2185-2191
To evaluate efficacy of, satisfaction with, and confidence in SDP (SUMAVEL DosePro *) among triptan users requiring a change in therapy. SDP is a needle-free, subcutaneous sumatriptan product that confers relief as early as 10 minutes postdose.In an
Publikováno v:
Pharmaceutical Research. 24:1501-1507
For a novel needle-free injection (NFI) system, the relationship between frequency of wet or incomplete injections and device-related factors and subject physiological variables was examined.A total of 26 device configurations of a single-use pre-fil
Publikováno v:
Clinical Pharmacology : Advances and Applications
Stephen J Farr,1 Cynthia Y Robinson,1 Christopher M Rubino2,3 1Zogenix, Inc., Emeryville, CA, 2Institute for Clinical Pharmacodynamics, Latham, NY, 3School of Pharmacy and Pharmaceutical Sciences, The State University of New York, University at Buffa
Autor:
Stephen J. Farr, Babatunde Otulana
Publikováno v:
Advanced Drug Delivery Reviews. 58:1076-1088
Pulmonary opioid delivery, on the basis of the fact that small molecular entities can be rapidly and completely absorbed from the peripheral lung, poses a unique opportunity for the treatment of severe (breakthrough) pain, which currently is treated
Autor:
Jerry Okikawa, Akwete Adjei, Rai-Yun Lee, Christine M. Woods, Anthony Queirolo, Franklin Okumu, Stephen J. Farr, Igor Gonda, Peter M. Lloyd, James Blanchard, Richard J. Bertz, Reid M. Rubsamen
Publikováno v:
Pharmaceutical Research. 19:1009-1012
Purpose. ABT-431 is a chemically stable, poorly soluble prodrug that rapidly converts in vivo to A-86929, a selective dopamine D-1 receptor agonist. This study was designed to evaluate the ability of the AERx™ pulmonary delivery system to deliver A
Autor:
Orlando G Florete, Srinivas Nalamachu, Stephen J Farr, Cynthia Y. Robinson, Richard Rauck, Martin E. Hale
Publikováno v:
Journal of Pain Research
Srinivas Nalamachu,1,2 Richard L Rauck,3 Martin E Hale,4 Orlando G Florete Jr,5 Cynthia Y Robinson,6 Stephen J Farr,6 1International Clinical Research Institute, Overland Park, KS, USA; 2Kansas University Medical Center, Kansas City, KS, USA; 3Caroli
Publikováno v:
Review of Industrial Organization. 18:147-160
The welfare effect of advertising restrictions in the U.S. cigarette industry depends upon the impact of advertising on consumer and producer surplus, the transfer to consumers for being exposed to utility-reducing advertising, and smoking externalit